Search

everythinglearnresearchcommunity

for

Search:↓

Diphencyprone is effective for treating patchy hair loss in alopecia areata, but tacrolimus is not.

Activating the Nrf2 pathway reduces inflammation and cell activation in human hair follicles, suggesting a potential treatment for certain hair loss conditions.

Blood-derived CD34+ cells speed up healing, reduce scarring, and regrow hair in skin wounds.

The document concludes that treatment for cutaneous T-cell lymphoma should be customized to each patient's disease stage, balancing benefits and side effects, with no cure but many patients living long lives.

Gamma delta T cells in the skin help with healing and defense but can also cause autoimmune issues, and more research is needed to understand how they are activated.

Mesenchymal stem cells show promise in treating COVID-19 by reducing inflammation and aiding recovery, but more research is needed.

The role of γδT-cells in causing alopecia areata remains unclear.

Epidermal stem cells could lead to new treatments for skin and hair disorders.

Environmental cues can change the fate and function of epithelial cells, with potential for cell therapy.

Damage to hair follicle stem cells may cause permanent hair loss and scarring in PCA.

CD4+ skin cells may be precursors to basal cell carcinoma.

Notch1 helps skin heal by attracting cells that aid repair.

Hair follicle stem cells are key for hair and skin regeneration, can be reprogrammed, and have potential therapeutic uses, but also carry a risk of cancer.

Skin aging is due to impaired stem cell mobilization or fewer responsive stem cells.

Different types of stem cells exist within individual skin layers, and they can adapt to damage, transplantation, or tumor growth. These cells are regulated by their environment and genetic factors. Tumor growth is driven by expanding, genetically altered cells, not long-lived mutant stem cells. There's evidence of cancer stem cells in skin tumors. Other cells, bacteria, and genetic factors help maintain balance and contribute to disease progression. A method for growing mini organs from single cells has been developed.

Dermal Papilla cells are a promising tool for evaluating hair growth treatments.

Valproic Acid could potentially be used to treat immune-related conditions due to its ability to modify immune cell functions.

Thymic transplantation normalized some T-cells but not others, maintaining immune function.

Regulatory T cells are essential for normal and improved wound healing in mice.

Mast cells might contribute to hair loss by causing skin thickening.

StemMACS media is better for growing therapeutic stem cells than PowerStem media.

Genetic mutation and carcinogen treatment are both needed for skin cancer to develop in these specific mice.

Rhododendrol in skin-whitening products can cause skin depigmentation and immune reactions.

IL-36α helps grow new hair follicles and speeds up wound healing.

KLF4 is important for maintaining stem cells and has potential in cancer treatment and wound healing.

Targeting the protein Caveolin-1 might help treat a type of scarring hair loss called Frontal Fibrosing Alopecia.

Certain types of T cells are essential for healthy skin and play a role in skin diseases, but more research is needed to improve treatments.

Lichen Planopilaris and Frontal Fibrosing Alopecia may help us understand hair follicle stem cell disorders and suggest new treatments.

Damaged hair follicle stem cells can cause permanent hair loss, but understanding their role could lead to new treatments.

A specific DNA region is crucial for Foxn1 gene expression in thymus cells but not in hair follicles.